The Alliance wants to ensure an FDA that is sized and modernized to meet its mandate in the 21st century. The FDA oversees products that represent 20% of consumer spending in the US and affect every American multiple times each day. Its responsibilities are global in scope and form the backbone of the world’s economy.
On behalf of the Academy of Managed Care Pharmacy (AMCP), I wanted to take this opportunity to express our strong support for the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974), bipartisan legislation to increase competition and patient access to safe and affordable generic and biosimilar medicines.
The Academy of Managed Care Pharmacy (AMCP) strongly supports the committee’s drive to combat the opioid epidemic. While searching for solutions to a widespread problem which has impacted the lives of many across the nation, there has been a consensus that no “one size fits all” solution exists and therefore AMCP believes that a holistic, comprehensive, and multi-stakeholder approach among health care providers and patients is necessary to truly address the opioid epidemic.
The Academy of Managed Care Pharmacy (AMCP) writes in strong opposition to House Bill 4146. House bill 4146 “prohibits a health care plan from modifying an enrollee’s drug coverage in a plan year by (A) increasing out-of-pocket costs for a covered drug; (B) moving a prescription to a more restrictive tier; or (C) removing a prescription drug from a formulary.”
The Academy of Managed Care Pharmacy (AMCP) opposes provisions in Assembly Bill 4306 that require a medication synchronization program to apply a daily pro-rated cost-sharing rate to prescriptions as determined by the health care practitioner and pharmacist which would abrogate existing health plan contract terms with the parties.
The Academy of Managed Care Pharmacy (AMCP) opposes provisions in Senate Bill 332 that require a medication synchronization program to apply a daily pro-rated cost-sharing rate to prescriptions as determined by the prescriber and pharmacist which would abrogate existing health insurance plan contract terms with the parties.